We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Jul 2020 - 30 Jul 2020


Image: Histopathology of cancerous breast tissue, the tumor cells have proliferated in a close pattern without tubular formation. This tumor represented moderately differentiated ductal carcinoma (Photo courtesy of The Japanese Society of Pathology).

Genetic Testing Benefits Postmenopausal Women with Breast Cancer

 Germline genetic testing for pathogenic variants (PVs) in cancer susceptibility genes after breast cancer diagnosis may inform cancer treatment, prevention, and testing of relatives. Postmenopausal women with breast cancer had a threefold higher prevalence of pathogenic variants in breast cancer-associated genes than their cancer-free counterparts. More...
26 Mar 2020
Image: Multitarget Stool DNA Screening has a high positive predictive value for colorectal neoplasia regardless of exposure to previous colonoscopy (Photo courtesy of Madeline Morr).

Multitarget Stool DNA Predicts Colorectal Neoplasia

 Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Screening is effective for preventing and decreasing deaths from colorectal cancer. More...
25 Mar 2020
Image: Circulating tumor DNA (ctDNA) assays can be used for the sensitive detection of minimal residual disease in patients treated for early-stage breast cancer (Photo courtesy of Natera).

Liquid Biopsy Assays Target Mutations and Improves Recurrence Prediction

 The concept of creating bespoke or personalized mutation panels to use for cancer recurrence detection and residual disease monitoring is not new at this point. Scientists began piloting these methods several years ago, initially tracking single mutations and then collections of alterations derived from tumor sequencing data. More...
25 Mar 2020
Image: The fully automated Idylla EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only one FFPE tissue section from metastatic non-small cell lung cancer (NSCLC) showing a high concordance of >95% compared with reference methods (Photo courtesy of Biocartis).

EGFR Mutation Assay Cartridges Evaluated

 Lung cancer remains the leading cause of cancer deaths. The management of lung cancer has been aided by the better understanding of molecular mechanisms involved in its initiation and progression and increased usage of molecular testing. More...
24 Mar 2020
Image: The XE-5000 Hematology Analyzer is a high volume analyzer that offers unique clinical parameters to aid in better patient care (Photo courtesy of Sysmex Corporation).

Prognostic Values of Platelet Parameters in Gynecological Tumors Patients

 Gynecologic cancers often involve the uterus, ovaries, cervix, vulva, vagina, fallopian tubes, or the peritoneum. The most common gynecologic cancer in the USA is endometrial cancer, followed by ovarian cancer. Many gynecologic cancers manifest as pelvic masses. More...
24 Mar 2020
Image: The IMMULITE 2000 XPi system is easy to use and has one of the largest automated immunoassay menus available. Medium- to high-volume laboratories can incorporate specialty and allergy testing into routine workloads to improve productivity and efficiency (Photo courtesy of Siemens Healthineers).

Combining Biomarkers Predicts Metastasis in Medullary Thyroid Carcinoma

 Medullary thyroid carcinoma (MTC) is a neuroendocrine neoplasm originating from thyroid parafollicular C cells and accounts for only 5% of all thyroid cancers, but its malignancy is relatively high, causing 8% to 13% of thyroid cancer‐related deaths due to its aggressiveness. More...
18 Mar 2020
Image: Schematic diagram of Neurofibromin as an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer (Photo courtesy of Baylor College of Medicine).

Neurofibromatosis Gene and Breast Cancer Resistance to Hormone Therapy

 The cells of estrogen receptor positive (ER+) breast cancer have receptors that allow them to use the hormone estrogen to grow. Treatment with anti-estrogen hormone (endocrine) therapy can block the growth of the cancer cells. More...
17 Mar 2020

The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2020 Globetech Media. All rights reserved.